These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 5483974)

  • 21. [Experimental validation of the use of alpha-adrenoblockers in combination with anticoagulants and fibrinolytic agents].
    Kalishevskaia TM; Golubeva MG; Bashkov GV
    Patol Fiziol Eksp Ter; 1988; (3):24-8. PubMed ID: 2902551
    [No Abstract]   [Full Text] [Related]  

  • 22. Possibilities of development of fibrinolytic activity with new and projected agents.
    Cliffton EE
    Angiologica; 1968; 5(2):146-60. PubMed ID: 4232515
    [No Abstract]   [Full Text] [Related]  

  • 23. Studies on the heterogeneity of fibrinolytic activity in artificially induced intravascular clots.
    Ban I
    Nagoya J Med Sci; 1967 Jun; 30(1):37-57. PubMed ID: 4229316
    [No Abstract]   [Full Text] [Related]  

  • 24. Tridegin, a novel peptidic inhibitor of factor XIIIa from the leech, Haementeria ghilianii, enhances fibrinolysis in vitro.
    Seale L; Finney S; Sawyer RT; Wallis RB
    Thromb Haemost; 1997 May; 77(5):959-63. PubMed ID: 9184410
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Basic principles of thrombolytic therapy].
    van de Loo J
    Internist (Berl); 1969 Jan; 10(1):16-21. PubMed ID: 4190309
    [No Abstract]   [Full Text] [Related]  

  • 26. [Behavior of postoperative adhesions after intraperitoneal administration of fibrinolytic drugs in a rat model].
    Stapel A; Geissler N; Mlasowsky B; Jung D
    Langenbecks Arch Chir; 1997; 382(1):33-6. PubMed ID: 9157230
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Immunologic evidence of products of fibrinolysis in the course of thrombolytic treatment].
    Mazák J; Matĕja F
    Vnitr Lek; 1971 Aug; 17(8):782-7. PubMed ID: 4998902
    [No Abstract]   [Full Text] [Related]  

  • 28. Prevention and therapy of experimental venous thrombosis in rabbits by desmin 370.
    Colucci M; Rossiello MR; Barbanti M; Calanni F; Semeraro N
    Thromb Haemost; 1998 Aug; 80(2):338-41. PubMed ID: 9716163
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Letter: Thrombolytic agents: are suitable methods used for their assessment? Are our investigative efforts directed toward the right goal?
    Von Kaulla KN
    Thromb Res; 1974 Feb; 4(2):367-73. PubMed ID: 4831010
    [No Abstract]   [Full Text] [Related]  

  • 30. [Pharmacological study of the streptokinase preparation, avelizin].
    Markwardt F; Klöcking HP
    Farmakol Toksikol; 1980; 43(6):671-4. PubMed ID: 7450003
    [No Abstract]   [Full Text] [Related]  

  • 31. Retinoic acid enhances fibrinolytic activity in-vivo by enhancing tissue type plasminogen activator (t-PA) activity and inhibits venous thrombosis.
    van Giezen JJ; Boon GI; Jansen JW; Bouma BN
    Thromb Haemost; 1993 Apr; 69(4):381-6. PubMed ID: 8497851
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mechanism of action of synthetic fibrinolytic compounds.
    Baumgarten W; Priester LI; Stiller DW; Duncan AE
    Thromb Diath Haemorrh; 1970 Dec; 24(3):495-506. PubMed ID: 5503944
    [No Abstract]   [Full Text] [Related]  

  • 33. The thrombolytic activity of streptokinase in the rabbit.
    English PD; Smith RA; Dupe RJ; Green J; Hibbs MJ
    Thromb Haemost; 1981 Aug; 46(2):535-7. PubMed ID: 7302893
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Thrombolytics and their use].
    Alessi MC; Juhan-Vague I
    Rev Prat; 1999 Oct; 49(15):1654-8. PubMed ID: 10581996
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Solubility of collagen in fibrinolytic agents].
    Schmitt W; Beneke G
    Klin Wochenschr; 1972 Mar; 50(6):335-7. PubMed ID: 4338646
    [No Abstract]   [Full Text] [Related]  

  • 36. Fibrinolytic agents.
    Schmitz-Huebner U; van de Loo J
    Clin Haematol; 1981 Jun; 10(2):481-96. PubMed ID: 7032785
    [No Abstract]   [Full Text] [Related]  

  • 37. Fibrinogen degradation products in plasma following induced hyperfibrinolysis.
    Chek JB; Panchenko NI
    East Afr Med J; 2000 Apr; 77(4):217-20. PubMed ID: 12858907
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Plasminogen activator from a kidney cell culture].
    Andreenko GV; Egorov BB; Liaginskiĭ AV; Serebriakova TN; Podorol'skaia LV
    Nauchnye Doki Vyss Shkoly Biol Nauki; 1983; (10):55-8. PubMed ID: 6686063
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fibrinolytic variables in patients with recurrent venous thrombosis: a prospective cohort study.
    Crowther MA; Roberts J; Roberts R; Johnston M; Stevens P; Skingley P; Patrassi GM; Sartori MT; Hirsh J; Prandoni P; Weitz JI; Gent M; Ginsberg JS
    Thromb Haemost; 2001 Mar; 85(3):390-4. PubMed ID: 11307802
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A comparison of acylated streptokinase-plasminogen complex and streptokinase in healthy volunteers.
    Prowse CV; Hornsey V; Ruckley CV; Boulton FE
    Thromb Haemost; 1982 Apr; 47(2):132-5. PubMed ID: 7048621
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.